The article argues that nuclear power is in a renaissance and highlights three beneficiaries: Cameco, Constellation Energy, and BWX Technologies. Cameco produced 15% of global uranium in 2025 and posted 11% revenue growth with a 16.9% net margin; Constellation owns 21 U.S. nuclear reactors, is targeting 2028 for the Three Mile Island restart with Microsoft, and delivered 8.3% revenue growth; BWX Technologies grew 2025 revenue 18% to $3.19 billion and EPS 20% while advancing its 75 MW small modular reactor for AI data centers. Overall, the piece is constructive on the nuclear sector and its role in AI and clean energy, but it is primarily commentary rather than a direct market-moving catalyst.
The real market signal is not “nuclear is back,” but that the scarcity premium is moving upstream and downstream at the same time. Uranium miners benefit first because fuel is the only part of the stack where incremental demand can be met with long lead times, so spot and term pricing can stay elevated even if reactor buildouts slip. That favors CCJ over pure-play reactor stories: it has a broader hedge across mining, fuel services, and Westinghouse exposure, which reduces single-point execution risk and gives it more ways to monetize a multi-year cycle. CEG is the cleaner duration trade on the power-demand side, but the Microsoft linkage matters more as a financing and credibility catalyst than as immediate earnings upside. If hyperscalers keep signing 15-20 year PPAs, nuclear moves from a policy story to a contracted infrastructure asset class, which should compress perceived merchant risk across the sector. The second-order winner is not just CEG; it’s every utility or IPP with an operating nuclear fleet and an attractive relicensing/uptime profile, while gas peakers and uncontracted baseload lose optionality as AI load grows. BWXT is the most interesting asymmetry because its upside depends less on broad adoption and more on whether the market starts capitalizing small-modular and naval nuclear capability at industrial rather than startup multiples. That said, the timing risk is large: SMR economics are still a demonstration problem, not a revenue problem, so the stock can outrun near-term deployability. The contrarian read is that the entire trade may be early by several years, but that is precisely when you want exposure to names with real cash flow, because they can survive the gestation period while venture-stage competitors dilute or die. Biggest reversal risks are policy and execution, not commodity demand. A safety incident, permitting delay, or overrated SMR commercialization path could de-rate the group quickly, while a sharp pullback in power-price expectations would hit the utilities/contracted-asset premium first. The trade should be treated as a 6-24 month thematic exposure, not a one-quarter momentum chase, with CCJ and CEG the lower-beta core and BWXT as the higher-volatility kicker.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment